Immunologic sensitization in recipients of left ventricular assist devices
- 1 March 2003
- journal article
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 125 (3), 578-591
- https://doi.org/10.1067/mtc.2003.30
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- B-Cell activation and allosensitization after left ventricular assist device implantation is due to T-Cell activation and CD40 ligand expressionHuman Immunology, 2002
- Impact of Current Management Practices on Early and Late Death in More Than 500 Consecutive Cardiac Transplant RecipientsAnnals of Surgery, 2000
- Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist de viceThe Lancet, 1999
- Long-term survival after cardiac retransplantation: A twenty-year single-center experienceThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Factors Influencing HLA Sensitization in Implantable LVAD RecipientsThe Annals of Thoracic Surgery, 1997
- The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantationTransplant Immunology, 1993
- OUTCOME OF CARDIAC TRANSPLANT RECIPIENTS WITH A POSITIVE DONOR-SPECIFIC CROSSMATCH—PRELIMINARY RESULTS WITH PLASMAPHERESISTransplantation, 1992
- Laboratory and clinical management of the highly sensitized organ transplant recipientHuman Immunology, 1989
- Significance of the Positive Crossmatch Test in Kidney TransplantationThe New England Journal of Medicine, 1969
- HYPERACUTE REJECTION OF KIDNEY ALLOGRAFTS, ASSOCIATED WITH PRE-EXISTING HUMORAL ANTIBODIES AGAINST DONOR CELLSThe Lancet, 1966